According to a recent KLAS report, Deloitte has been rated the top firm for ACO strategy development and readiness assessment. The report, ACO Advisory Services 2014: Navigating the Unchartered Territory of Accountable Care, evaluates seven firms based on interviews with 41 health care organizations working to implement value-based care models against three categories:
– strategy development
– readiness assessment
The KLAS report gave Deloitte its highest score for preparing healthcare organizations for the transition to a value-based care model. Key drivers for Deloitte high rating include:
– Having “deep health care resources”
– Being “superb in guiding some of the most progressive clients and most complex projects in strategy-development work”
– Customers express most confidence in moving forward with Deloitte’s created strategy/infrastructure
“This is a whole new world that providers are entering, and there are still a lot of unknowns,” said KLAS senior research manager Mark Allphin. “Providers, payers and consultants are still often learning as they go along, and these reports reflect that.”
Jason Girzadas, principal, Deloitte Consulting LLP, and national leader for Deloitte’s life sciences and health care practice, believes the ratings validate Deloitte’s enterprise-wide, multi-disciplinary approach to ACO services.
Other firms included in the report are Accenture Health, Advisory Board, Evolent Health, Premier, PwC and xG Health.
As one of the nation’s largest consulting firms to the health care industry, Deloitte brings an end-to-end view to value-based care drawing on world-class experiences in strategy, performance excellence, clinical redesign, applied analytics, digital solutions, talent management and technology transformation.
Deloitte has also made a major move into the health analytics space with the roll-out of ConvergeHEALTH by Deloitte, a consortium of premier health organizations working to break down barriers in helping providers, plans and life sciences companies transform around personalized medicines and population health. Deloitte has invested $150 million in ConvergeHEALTH, which would make it one of the best-funded health analytic start-ups in the country if it were a stand-alone business.